 |
인쇄하기
취소
|
Daewoong Achieves Import of Its BT-Based Treatment, Easyef, to Middle East Market
Daewoong Pharmaceutical announced on December 17th that the company’s next-generation drug, Easyef, has received a marketing permission from Jordan, providing an entry to the Middle East market starting Year 2005.
Daewoong’s Easyef, a spray-type external preparation, is for treatment of diabetic foot ulcer using the recombinant human Epidermal Growth Factor (rhEGF) as its active ingredient....
Daewoong’s Easyef, a spray-type external preparation, is for treatment of diabetic foot ulcer using the recombinant human Epidermal Growth Factor (rhEGF) as its active ingredient....
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.